NCT00818363View on ClinicalTrials.gov

A Safety and Effectiveness Study of SABER®-Bupivacaine for Pain Following Shoulder Surgery

PHASE2CompletedINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions

Postoperative Pain

Interventions

DRUG

SABER-Bupivacaine

Injectable Extended Release Solution; 5.0 mL SABER-Bupivacaine/Once

DRUG

SABER-Placebo

Injectable Solution; 5.0 mL SABER-Placebo/Once

Trial Locations (9)

2145

Westmead

3135

Ringwood East

3188

Hampton

3220

Geelong

4021

Kippa-Ring

5000

Adelaide

5065

Toorak Gardens

Unknown

Christchurch

Hamilton

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors

collaborator

Nycomed

INDUSTRY

lead

Durect

INDUSTRY